Veozah 45 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQ67F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,011
Award facts
- Contract value 100% obligated
- $12,010.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,010.96 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Veozah is a prescription medication used in menopausal hormone therapy, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies through federal procurement channels.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion pharmaceutical supply vehicle running through December 2026 that enables the company to distribute an extensive range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. As a major pharmaceutical distributor and prime contractor for federal medical procurement, AmerisourceBergen regularly fulfills small-to-large-value orders across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support is planning successor Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen competitively within the federal pharmaceutical supply landscape.
Quick answers
Who was awarded contract SPE2DB25FQ67F?
SPE2DB25FQ67F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FQ67F worth?
The government has obligated $12,011 on SPE2DB25FQ67F.
Is contract SPE2DB25FQ67F an order under another contract?
Yes. SPE2DB25FQ67F is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ67F competed?
The extent of competition for SPE2DB25FQ67F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award